These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 6861143
21. Assay of human thyroid glands for thyrocalcitonin activity. Aliapoulios MA, Voelkel EF, Munson PL. J Clin Endocrinol Metab; 1966 Aug; 26(8):897-901. PubMed ID: 5921158 [No Abstract] [Full Text] [Related]
22. Calcitonin in breast and lung cancer. Hillyard CJ, Coombes RC, Greenberg PB, Galante LS, MacIntyre I. Clin Endocrinol (Oxf); 1976 Jan; 5(1):1-8. PubMed ID: 942890 [Abstract] [Full Text] [Related]
23. Development and validation of an assay to measure bioactivity of human calcitonin in vitro using T47D cell membranes. Blind E, Raue F, Kienle P, Schroth J, Grauer A, Kabay A, Brügger P, Ziegler R. Anal Biochem; 1993 Jul; 212(1):91-7. PubMed ID: 8396366 [Abstract] [Full Text] [Related]
24. Adrenocorticotropin and calcitonin in medullary thyroid carcinoma: frequency of occurrence and localization in the same cell type by immunocytochemistry. Goltzman D, Huang SN, Browne C, Solomon S. J Clin Endocrinol Metab; 1979 Sep; 49(3):364-9. PubMed ID: 224074 [No Abstract] [Full Text] [Related]
25. Calcitonin- and katacalcin-like immunoreactivity in human seminal plasma. Maier U, Woloszczuk W, Schuh H, Zechner O. Exp Clin Endocrinol; 1986 Nov; 88(1):89-94. PubMed ID: 3817006 [Abstract] [Full Text] [Related]
26. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension. Chunxiao W, Jingjing L, Yire X, Min D, Zhaohui W, Gaofu Q, Xiangchun S, Xuejun W, Jie W, Taiming L. Regul Pept; 2007 Jun 07; 141(1-3):35-43. PubMed ID: 17300845 [Abstract] [Full Text] [Related]
27. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. Bugalho MJ, Santos JR, Sobrinho L. J Surg Oncol; 2005 Jul 01; 91(1):56-60. PubMed ID: 15999359 [Abstract] [Full Text] [Related]
28. Immunocytochemical localisation of katacalcin, a calcium-lowering hormone cleaved from the human calcitonin precursor. Ali-Rachedi A, Varndell IM, Facer P, Hillyard CJ, Craig RK, MacIntyre I, Polak JM. J Clin Endocrinol Metab; 1983 Sep 01; 57(3):680-2. PubMed ID: 6348069 [Abstract] [Full Text] [Related]
29. Immunoelectron microscopic demonstration of regulated pathway for calcitonin and constitutive pathway for carcinoembryonic antigen in the same cells of human medullary carcinomas of thyroid glands. Osamura RY, Yasuda O, Kawakami T, Itoh Y, Inada K, Kakudo K. Mod Pathol; 1997 Jan 01; 10(1):7-11. PubMed ID: 9021721 [Abstract] [Full Text] [Related]
30. Radioreceptor assay for the detection of biologically active forms of calcitonin [proceedings]. Ham J, Williams JC, Ellison ML. J Endocrinol; 1979 May 01; 81(2):152P-153P. PubMed ID: 458330 [No Abstract] [Full Text] [Related]
31. Localization of a radiolabeled monoclonal antibody to calcitonin in rat medullary thyroid carcinoma allografts. Samaan NA, Yang KP. Henry Ford Hosp Med J; 1987 May 01; 35(2-3):153-6. PubMed ID: 3692888 [No Abstract] [Full Text] [Related]
32. Immunochemical and biological characterization of calcitonin originating from transplanted medullary thyroid carcinoma in rats. Myhre L, Ekeland A, Gautvik KM. Acta Endocrinol (Copenh); 1982 Mar 01; 99(3):397-403. PubMed ID: 7072448 [Abstract] [Full Text] [Related]
33. Pancreatic polypeptide immunoreactivity in medullary carcinoma of the thyroid: identification and characterisation by radioimmunoassay, immunocytochemistry and high performance liquid chromatography. O'Hare MM, Shaw C, Johnston CF, Russell CF, Sloan JM, Buchanan KD. Regul Pept; 1986 Apr 01; 14(2):169-80. PubMed ID: 2872701 [Abstract] [Full Text] [Related]
34. Purification and amino acid sequence of a noncalcitonin secretory peptide derived from preprocalcitonin. Birnbaum RS, Mahoney W, Roos BA. J Biol Chem; 1983 May 10; 258(9):5463-6. PubMed ID: 6853528 [Abstract] [Full Text] [Related]
35. Presence of adrenocorticotropin-potentiating activity in a calcitonin preparation derived from porcine thyroid glands. Iida S, Itoh Y, Moriwaki K. Pharmacology; 1982 May 10; 24(4):211-4. PubMed ID: 6283570 [Abstract] [Full Text] [Related]
36. [Partial purification of calcitonin by molecular filtration on Sephadex]. Holak H, Matuszewski W, Wolnik A. Pol Tyg Lek; 1970 Dec 07; 25(49):1884-6. PubMed ID: 5492683 [No Abstract] [Full Text] [Related]
37. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease. Saller B, Görges R, Reinhardt W, Haupt K, Janssen OE, Mann K. Clin Lab; 2002 Dec 07; 48(3-4):191-200. PubMed ID: 11934221 [Abstract] [Full Text] [Related]
38. The effect of thyrocalcitonin in neonatal animals. Phillippo M, Care AD, Hinde FR. J Endocrinol; 1969 Jan 07; 43(1):xv-xvi. PubMed ID: 5789236 [No Abstract] [Full Text] [Related]
39. Acute and chronic fluctuations of immunoreactive and biologically active plasma calcitonin in the rat. Roos BA, Cooper CW, Frelinger AL, Deftos LJ. Endocrinology; 1978 Dec 07; 103(6):2180-6. PubMed ID: 748041 [Abstract] [Full Text] [Related]
40. [Calcitonin levels in tissue culture of thyroid medullary carcinoma]. Martin RC, Ezabella MC, Toledo SP. Rev Hosp Clin Fac Med Sao Paulo; 1985 Dec 07; 40(5):220-2. PubMed ID: 3836475 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]